Literature DB >> 27601547

Metabolic Tumor Volume in Lymphoma: Hype or Hope?

Heiko Schöder1, Craig Moskowitz1.   

Abstract

Entities:  

Year:  2016        PMID： 27601547      PMCID： PMC5547014          DOI： 10.1200/JCO.2016.69.3747

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

1.  Anatomy of SUV. Standardized uptake value.

Authors:  S C Huang
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

2.  Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response.

Authors:  Anne-Ségolène Cottereau; Hélène Lanic; Sylvain Mareschal; Michel Meignan; Pierre Vera; Hervé Tilly; Fabrice Jardin; Stéphanie Becker
Journal:  Clin Cancer Res       Date:  2016-07-01       Impact factor: 12.531

Review 3.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

4.  Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

Authors:  A S Cottereau; S Becker; F Broussais; O Casasnovas; S Kanoun; M Roques; N Charrier; S Bertrand; R Delarue; C Bonnet; R Hustinx; P Gaulard; L de Leval; P Vera; E Itti; N Mounier; C Haioun; H Tilly; M Meignan
Journal:  Ann Oncol       Date:  2016-01-19       Impact factor: 32.976

5.  Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Authors:  W Wang; S M Larson; M Fazzari; S K Tickoo; K Kolbert; G Sgouros; H Yeung; H Macapinlac; J Rosai; R J Robbins
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

7.  Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.

Authors:  Yingye Zheng; Tianxi Cai; Ziding Feng
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

8.  Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Anne-Ségolène Cottereau; Hélène Lanic; Sylvain Mareschal; Michel Meignan; Pierre Vera; Hervé Tilly; Fabrice Jardin; Stéphanie Becker
Journal:  Clin Cancer Res       Date:  2016-03-02       Impact factor: 12.531

9.  Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.

Authors:  Go Akamatsu; Katsuhiko Mitsumoto; Takafumi Taniguchi; Yuji Tsutsui; Shingo Baba; Masayuki Sasaki
Journal:  Eur J Radiol       Date:  2013-10-06       Impact factor: 3.528

10.  Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.

Authors:  N George Mikhaeel; Daniel Smith; Joel T Dunn; Michael Phillips; Henrik Møller; Paul A Fields; David Wrench; Sally F Barrington
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-23       Impact factor: 9.236
View more
  21 in total

1.  Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.

Authors:  Neha Mehta-Shah; Kimiteru Ito; Kurt Bantilan; Alison J Moskowitz; Craig Sauter; Steven M Horwitz; Heiko Schöder
Journal:  Blood Adv       Date:  2019-01-22

2.  Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816.

Authors:  Chul S Ha; Michael LeBlanc; Heiko Schöder; Chelsea C Pinnix; Nancy L Bartlett; Andrew M Evens; Eric D Hsi; Lisa Rimsza; Michael V Knopp; Jun Zhang; John P Leonard; Brad S Kahl; Hongli Li; Sonali Smith; Louis S Constine; Jonathan W Friedberg
Journal:  Leuk Lymphoma       Date:  2020-05-26

3.  Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Authors:  Alison J Moskowitz; Heiko Schöder; Somali Gavane; Katie L Thoren; Martin Fleisher; Joachim Yahalom; Susan J McCall; Briana R Cadzin; Stephanie Y Fox; John Gerecitano; Ravinder Grewal; Paul A Hamlin; Steven M Horwitz; Anita Kumar; Matthew Matasar; Andy Ni; Ariela Noy; M Lia Palomba; Miguel-Angel Perales; Carol S Portlock; Craig Sauter; David Straus; Anas Younes; Andrew D Zelenetz; Craig H Moskowitz
Journal:  Blood       Date:  2017-09-05       Impact factor: 22.113

4.  Evolution of lymphoma staging and response evaluation: current limitations and future directions.

Authors:  Joel Cunningham; Sunil Iyengar; Bhupinder Sharma
Journal:  Nat Rev Clin Oncol       Date:  2017-06-13       Impact factor: 66.675

5.  Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden.

Authors:  Sally F Barrington; Michel Meignan
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

6.  Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy.

Authors:  Kimiteru Ito; Heiko Schöder; Rebecca Teng; John L Humm; Ai Ni; Jedd D Wolchok; Wolfgang A Weber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-11-28       Impact factor: 9.236

7.  Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.

Authors:  Chelsea C Pinnix; Andrea K Ng; Bouthaina S Dabaja; Sarah A Milgrom; Jillian R Gunther; C David Fuller; Grace L Smith; Zeinab Abou Yehia; Wei Qiao; Christine F Wogan; Mani Akhtari; Osama Mawlawi; L Jeffrey Medeiros; Hubert H Chuang; William Martin-Doyle; Philippe Armand; Ann S LaCasce; Yasuhiro Oki; Michelle Fanale; Jason Westin; Sattva Neelapu; Loretta Nastoupil
Journal:  Blood Adv       Date:  2018-06-12

8.  Non-Hodgkin Lymphoma Metabolism.

Authors:  Brian James Kirsch; Shu-Jyuan Chang; Michael James Betenbaugh; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.

Authors:  Ajay Major; Andrew Hammes; Matthew Q Schmidt; Rustain Morgan; Diana Abbott; Manali Kamdar
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-09-28

Review 10.  A picture is worth a thousand words: a history of diagnostic imaging for lymphoma.

Authors:  N Ari Wijetunga; Brandon Stuart Imber; James F Caravelli; N George Mikhaeel; Joachim Yahalom
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.